Aktieanalys

Scanfil: Q2 EBIT below consensus, guidance unchanged - Nordea

Nordea Publicerad: 05 Aug 2022 08:31

Net sales was in line with consensus (Refinitiv) in Q2. However, operating profit was 10% below consensus in Q2. EBIT margin was only 4.8% in Q2 compared to long term target of 7%. Reasons for a weak EBIT were related to China, FX and to poor availability of components but Scanfil expects the operating profit to develop positively in H2 2022. We see it realistic that EBIT in H2 2022 could be higher than year ago and also higher than in H1 2022. But we forecast lower net sales for next year y/y because improving component availability. Record-high component prices cannot last forever. Full year net sales and EBIT guidance were unchanged. We believe market consensus EBIT for 2022E could come down by 2-4%.

Länk till analysen i sin helhet: https://research.nordea.com/api/reportfileapi?id=788677

Nyheter om Scanfil

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!